Registered the biosimilar EPO(Panpotin 2000IU) in Thailand

Registered the biosimilar EPO(Panpotin 4000IU) in Thailand

Registered the biosimilar EPO(Panpotin 2000IU) in KSA

Registered the biosimilar EPO(Panpotin 4000IU) in KSA

Registered the biosimilar EPO(ERYSAA 2000IU) in Philippines

Registered the biosimilar EPO(ERYSAA 4000IU) in Philippines

Received the certificate of GMP compliance of A manufacturer(PIC/s cGMP)

Signed a strategic investment contract with Huons Group for biopharmaceutical business cooperation

Received the HALAL certificate of EPO biosimilar

Joint R&D MOU for COVID-19 development with International Vaccine Institute(IVI)

Registered the biosimilar EPO(ERYSAA) in Malaysia

Registered the biosimilar EPO(Panpotin ) in Korea

Registered the biosimilar EPO product for export in Korea

Received the certificate of GMP Compliance of a Manufacturer(MFDS)

Signed the MOU for biopharmaceutical technology transfer with SaudiVax(KSA)

Contracted the CMO agreement for next-generation EPO with YLB(JP)

Listed company in KOSDAQ

Received the certificate of PIC/s cGMP for Biosimilar EPO product form Malaysia NPCB

Nominated K-Brain power company from MOTIE

Technology transfer service to Beijing Northland Biotech Co(China, Hemophilia treatments)

Nominated Minister Award for National R&D Excellence from MSIFP

Technology transfer service to TPI (USA, Antibody drug)
Technology transfer service to Beijing Tide pharma (China, Antibody drug)
Technology transfer service to Vitane pharma (UAE, Antibody drug)

Nominated Minister Award for Biotechnology Excellence from MOTIE

Technology transfer service to TPI (USA, Antibody drug)
Technology transfer service to Beijing Tide pharma (China, Fertility treatments)
Technology transfer service to Sophia pharma (Mexico, Antibody drug)

Multinational joint clinical trial of biosimilar EPO and marketing license contract with CCMB(Malaysia)

Technology transfer service to Beijing Northland Biotech Co(China, Hemophilia treatments)
Technology transfer service to IQFA(Mexico, Multiple sclerosis treatments)
Technology transfer service to TPI(USA, Antibody drug)